|
IDH3A expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.59340000000152E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.029840E-04 |
| Normal-vs-Stage2 |
3.169000E-01 |
| Normal-vs-Stage3 |
9.05609998103074E-09 |
| Normal-vs-Stage4 |
1.81509999996887E-06 |
| Stage1-vs-Stage2 |
1.181700E-02 |
| Stage1-vs-Stage3 |
2.477500E-03 |
| Stage1-vs-Stage4 |
4.239700E-02 |
| Stage2-vs-Stage3 |
6.958500E-04 |
| Stage2-vs-Stage4 |
1.082030E-03 |
| Stage3-vs-Stage4 |
9.977600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.28560000043099E-07 |
| Normal-vs-AfricanAmerican |
2.317100E-03 |
| Normal-vs-Asian |
4.642100E-03 |
| Caucasian-vs-AfricanAmerican |
7.714600E-01 |
| Caucasian-vs-Asian |
5.757400E-01 |
| AfricanAmerican-vs-Asian |
8.726600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.87180000000131E-05 |
| Normal-vs-Female |
1.590620E-04 |
| Male-vs-Female |
3.200400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.608900E-04 |
| Normal-vs-Age(41-60Yrs) |
2.12050000003572E-06 |
| Normal-vs-Age(61-80Yrs) |
1.147990E-01 |
| Normal-vs-Age(81-100Yrs) |
1.560850E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.102000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.055200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.691800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.505800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.159200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.531700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.382450E-03 |
| Classical-VS-Follicular |
1.757620E-04 |
| Classical-VS-Other |
3.725000E-01 |
| Classical-VS-Normal |
1.68560000002316E-06 |
| Tall-VS-Follicular |
2.26359999966341E-07 |
| Tall-VS-Other |
6.332600E-01 |
| Tall-VS-Normal |
4.46939996123774E-09 |
| Follicular-VS-Other |
1.996970E-03 |
| Follicular-VS-Normal |
4.312000E-01 |
| Other-VS-Normal |
2.798900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.169700E-04 |
| Normal-vs-N1 |
3.81650000491618E-09 |
| N0-vs-N1 |
4.838000E-04 |
|
|
